Emily Porter, M.D., P.A. – Trademark Portfolio
Entity Type: 99
Emily Porter, M.D., P.A. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AUSTIN LOVE DOCTOR. The owner is based in Leander, TX.
15609 Ronald Reagan Blvd., Bldg B-210
Leander, TX 78641
Showing of trademarks Trademarks
Trademark Classifications
Emily Porter, M.D., P.A.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Emily Porter, M.D., P.A. have?
Emily Porter, M.D., P.A. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Emily Porter, M.D., P.A. file in?
Emily Porter, M.D., P.A. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are Emily Porter, M.D., P.A.'s most well-known trademarks?
Emily Porter, M.D., P.A.'s registered trademark portfolio includes well-known marks such as AUSTIN LOVE DOCTOR. These are among 1 currently registered trademark in the portfolio.
What is Emily Porter, M.D., P.A.'s trademark registration success rate?
Emily Porter, M.D., P.A. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.